Patient info Open main menu

Mezzopram 20 mg dispersible gastro-resistant tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
20 mg
Contains active substance:
ATC code:

Patient leaflet - Mezzopram 20 mg dispersible gastro-resistant tablets

1 What Mezzopram is and what it is used for

Mezzopram Dispersible gastro-resistant tablets contain the active substance omeprazole. It belongs to a group of medicines called ‘proton pump inhibitors’. They work by reducing the amount of acid that your stomach produces.

Mezzopram is used to treat the following conditions: In adults:

  • ‘Gastro-oesophageal reflux disease’ (GORD). This is where acid from the stomach escapes into the gullet (the tube which connects your throat to your stomach) causing pain, inflammation and heartburn.
  • Ulcers in the upper part of the intestine (duodenal ulcer) or stomach (gastric ulcer).
  • Ulcers which are infected with bacteria called ‘Helicobacter pylori’. If you have this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.
  • Ulcers caused by medicines called NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). Mezzopram can also be used to stop ulcers from forming if you are taking NSAIDs.
  • Too much acid in the stomach caused by a growth in the pancreas (Zollinger-Ellison syndrome).

In children:

Children over 1 year of age and ≥ 10 kg

  • ‘Gastro-oesophageal reflux disease’ (GORD). This is where acid from the stomach escapes into the gullet (the tube which connects your throat to your stomach) causing pain, inflammation and heartburn.

    In children, the symptoms of the condition can include the return of stomach contents into the mouth (regurgitation), being sick (vomiting) and poor weight gain.

Children over 4 years of age and adolescents

  • Ulcers which are infected with bacteria called ‘Helicobacter pylori’. If your child has this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.

2 What you need to know before you take

Mezzopram

Do not take Mezzopram

  • if you are allergic to omeprazole or any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic to medicines containing other proton pump inhibitors (e.g. pantoprazole, lansoprazole, rabeprazole, esomeprazole).
  • if you are taking a medicine containing nelfinavir (for HIV infection).

Do not take Mezzopram if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Mezzopram.

Warnings and precautions

Talk to your doctor or pharmacist before taking Mezzopram.

Serious skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS) and acute generalized exanthematous pustulosis (AGEP) have been reported in association with Omeprazole treatment. Stop using Omeprazole and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.

Mezzopram may hide the symptoms of other diseases. Therefore, if any of the following happen to you before you start taking Mezzopram or while you are taking it, talk to your doctor straight away:

  • You lose a lot of weight for no reason and have problems swallowing.
  • You get stomach pain or indigestion.
  • You begin to vomit food or blood.
  • You pass black stools (blood-stained faeces).
  • You experience severe or persistent diarrhoea, as omeprazole has been associated with a small increase in infectious diarrhoea.
  • You have severe liver problems.
  • You are due to have a specific blood test (Chromogranin A).
  • You have ever had a skin reaction after treatment with a medicine similar to Mezzopram that reduces stomach acid.

If you take Mezzopram on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance. You should report any new and exceptional symptoms and circumstances whenever you see your doctor.

When taking omeprazole, inflammation in your kidney may occur. Signs and symptoms may include decreased volume of urine or blood in your urine and/or hypersensitivity reactions such as fever, rash, and joint stiffness. You should report such signs to the treating physician.

Taking a proton pump inhibitor like Mezzopram, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).

If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Mezzopram. Remember to also mention any other ill-effects like pain in your joints.

This medicine may affect the way that your body absorbs vitamin B12, particularly if you need to take it for a long time. Please contact your doctor if you notice any of the following symptoms, which could indicate low levels of vitamin B12:

  • Extreme tiredness or lack of energy
  • Pins and needles
  • Sore or red tongue, mouth ulcers
  • Muscle weakness

    • Disturbed vision
    • Problems with memory, confusion, depression

Children

Some children with chronic illnesses may require long-term treatment although it is not recommended. Do not give this medicine to children under 1 year of age or < 10 kg.

Other medicines and Mezzopram

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription. This is because Mezzopram can affect the way some medicines work and some medicines can have an effect on Mezzopram.

Do not take Mezzopram if you are taking a medicine containing nelfinavir (used to treat HIV infection).

Tell your doctor or pharmacist if you are taking any of the following medicines:

  • Ketoconazole, itraconazole, posaconazole or voriconazole (used to treat infections caused by a fungus).
  • Digoxin (used to treat heart problems).
  • Diazepam (used to treat anxiety, relax muscles or in epilepsy).
  • Phenytoin (used in epilepsy). If you are taking phenytoin, your doctor will need to monitor you when you start or stop taking Mezzopram.
  • Medicines that are used to thin your blood, such as warfarin or other vitamin K blockers. Your doctor may need to monitor you when you start or stop taking Mezzopram.
  • Rifampicin (used to treat tuberculosis).
  • Atazanavir (used to treat HIV infections).
  • Tacrolimus (in cases of organ transplantation).
  • St John’s wort (Hypericum perforatum) (used to treat mild depression).
  • Cilostazol (used to treat intermittent claudication).
  • Saquinavir (used to treat HIV infection).
  • Clopidogrel (used to prevent blood clots (thrombi)).
  • Erlotinib (used to treat cancer).
  • Methotrexate (a chemotherapy medicine used in high doses to treat cancer) – if you are taking a high dose of methotrexate, your doctor may temporarily stop your Mezzopram treatment.

If your doctor has prescribed the antibiotics amoxicillin and clarithromycin as well as Mezzopram to treat ulcers caused by Helicobacter pylori infection, it is very important that you tell your doctor about any other medicines you are taking.

Mezzopram with food and drink

See section 3.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Omeprazole is excreted in breast milk but is not likely to influence the child when therapeutic doses are used.

Your doctor will decide whether you can take Mezzopram if you are breast-feeding.

Driving and using machines

Mezzopram is not likely to affect your ability to drive or use any tools or machines. Side effects such as dizziness and visual disturbances may occur (see section 4). If affected, you should not drive or operate machinery.

Mezzopram gastro-resistant tablets contain glucose and sucrose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3 How to take Mezzopram

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Your doctor will tell you how many tablets to take and how long to take them for. This will depend on your condition and how old you are.

The recommended dose is given below:

Adults:

To treat symptoms of GORD such as heartburn and acid regurgitation:

  • If your doctor has found that your food pipe (gullet) has been slightly damaged, the recommended dose is 20 mg once a day for 4-8 weeks. Your doctor may tell you to take a dose of 40 mg for a further 8 weeks if your gullet has not yet healed.
  • The recommended dose once the gullet has healed is 10 mg once a day.
  • If your gullet has not been damaged, the usual dose is 10 mg once a day.

To treat ulcers in the upper part of the intestine (duodenal ulcer):

  • The recommended dose is 20 mg once a day for 2 weeks. Your doctor may tell you to take the same dose for a further 2 weeks if your ulcer has not yet healed.
  • If the ulcers does not fully heal, the dose can be increased to 40 mg once a day for 4 weeks.

To treat ulcers in the stomach (gastric ulcer):

  • The recommended dose is 20 mg once a day for 4 weeks. Your doctor may tell you to take the same dose for a further 4 weeks if your ulcer has not yet healed.
  • If the ulcers does not fully heal, the dose can be increased to 40 mg once a day for 8 weeks.

To prevent the duodenal and stomach ulcers from coming back:

  • The recommended dose is 10 mg or 20 mg once a day. Your doctor may increase the dose to 40 mg once a day.

To treat duodenal and stomach ulcers caused by NSAIDs (Non-Steroidal Anti-Inflammatory Drugs):

  • The recommended dose is 20 mg once a day for 4 to 8 weeks.

    SZ00000LT000

PIL.1077-1079.016.0D Continued on the next page >> To prevent duodenal and stomach ulcers if you are taking NSAIDs:

  • The recommended dose is 20 mg once a day.

To treat ulcers caused by Helicobacter pylori infection and to stop them coming back:

  • The recommended dose is 20 mg Mezzopram twice a day for one week.
  • Your doctor will also tell you to take two antibiotics among amoxicillin, clarithromycin and metronidazole.

To treat too much acid in the stomach caused by a growth in the pancreas (Zollinger-Ellison syndrome):

  • The recommended dose is 60 mg daily.
  • Your doctor will adjust the dose depending on your needs and will also decide how long you need to take the medicine for.

Use in Children and adolescents

To treat symptoms of GORD such as heartburn and acid regurgitation:

  • Children over 1 year of age and with a body weight of more than 10 kg may take Mezzopram. The dose for children is based on the child’s weight and the doctor will decide the correct dose.

To treat ulcers caused by Helicobacter pylori infection and to stop them coming back:

  • Children aged over 4 years may take Mezzopram. The dose for children is based on the child’s weight and the doctor will decide the correct dose.
  • Your doctor will also prescribe two antibiotics called amoxicillin and clarithromycin for your child.

Taking this medicine

It is recommended that you take your tablets in the morning. You can take your tablets with food or on an empty stomach. Swallow your tablets whole with half a glass of water. Do not chew or crush the tablets. This is because the tablets contain coated pellets which stop the medicine from being broken down by the acid in your stomach. It is important not to damage the pellets.

What to do if you or your child have trouble swallowing the tablets

If you or your child have trouble swallowing the tablets:

  • Break the tablet and disperse it in a spoonful of water

    (non-fizzy), any acidic fruit juice (e.g. apple, orange or pineapple) or apple sauce.

  • Always stir the mixture just before drinking (the mixture will

    not be clear). Then drink the mixture straight away or within 15 minutes.

  • To make sure that you have drunk all of the medicine, rinse

    the glass very well with half a glass of water and drink it. Do not use milk or fizzy water. The solid pieces contain the medicine - do not chew or crush them.

If you take more Mezzopram than you should

If you take more Mezzopram than prescribed by your doctor, talk to your doctor or pharmacist straight away.

If you forget to take Mezzopram

If you forget to take a dose, take it as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.

If you stop taking Mezzopram

Do not stop taking Mezzopram without first talking to your doctor or pharmacist.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

The 20 mg and 40 mg tablet can be divided into equal doses.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you notice any of the following rare (may affect up to 1 in 1,000 people) or very rare (may affect up to 1 in 10,000 people) but serious side effects, stop taking Mezzopram and contact a doctor immediately:

  • Sudden wheezing, swelling of your lips, tongue and throat or body, rash, fainting or difficulties in swallowing (severe allergic reaction). (rare)
  • Reddening of the skin with blisters or peeling. There may also be severe blisters and bleeding in the lips, eyes, mouth, nose and genitals. This could be ‘Stevens-Johnson syndrome’ or ‘toxic epidermal necrolysis’. (very rare)
  • Widespread rash, high body temperature and enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome). (rare)
  • A red, scaly widespread rash with bumps under the skin and blisters accompanied by fever. The symptoms usually appear at the initiation of treatment (acute generalized exanthematous pustulosis). (rare)
  • Yellow skin, dark urine and tiredness which can be symptoms of liver problems.

Other side effects include:

Common side effects (may affect up to 1 in 10 people)

  • Headache.
  • Effects on your stomach or gut: diarrhoea, stomach pain, constipation, wind (flatulence).
  • Feeling sick (nausea) or being sick (vomiting).
  • Benign polyps in the stomach.

Uncommon side effects (may affect up to 1 in 100 people)

  • Swelling of the feet and ankles.
  • Disturbed sleep (insomnia).
  • Dizziness, tingling feelings such as “pins and needles”, feeling sleepy.
  • Spinning feeling (vertigo).
  • Changes in blood tests that check how the liver is working.
  • Skin rash, lumpy rash (hives) and itchy skin.
  • Generally feeling unwell and lacking energy.
  • Fracture in the hip, wrist or spine

Rare side effects (may affect up to 1 in 1,000 people)

  • Blood problems such as a reduced number of white cells or platelets. This can cause weakness, bruising or make infections more likely.
  • Low levels of sodium in the blood. This may cause weakness, being sick (vomiting) and cramps.
  • Feeling agitated, confused or depressed.
  • Taste changes.
  • Eyesight problems such as blurred vision.
  • Suddenly feeling wheezy or short of breath (bronchospasm).
  • Dry mouth.
  • An inflammation of the inside of the mouth.
  • An infection called “thrush” which can affect the gut and is caused by a fungus.
  • Hair loss (alopecia).
  • Skin rash on exposure to sunshine.
  • Joint pains (arthralgia) or muscle pains (myalgia).
  • Severe kidney problems (interstitial nephritis).
  • Increased sweating.

Very rare side effects (may affect up to 1 in 10,000 people)

  • Changes in blood count including agranulocytosis (lack of white blood cells)
  • Aggression.
  • Seeing, feeling or hearing things that are not there (hallucinations).
  • Severe liver problems leading to liver failure and inflammation of the brain.
  • Erythema multiforme
  • Muscle weakness.
  • Enlarged breasts in men.

    Not known (frequency cannot be estimated from the available data)

    • Inflammation in the gut (leading to diarrhoea).
    • If you are on Mezzopram for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness or increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.
    • Rash, possibly with pain in the joints.

Mezzopram may in very rare cases affect the white blood cells leading to immune deficiency. If you have an infection with symptoms such as fever with a severely reduced general condition or fever with symptoms of a local infection such as pain in the neck, throat or mouth or difficulties in urinating, you must consult your doctor as soon as possible so that a lack of white blood cells (agranulocytosis) can be ruled out by a blood test. It is important for you to give information about your medicine at this time.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (www.mhra.gov.uk/yellowcard). By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Mezzopram

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the outer and inner pack after EXP. The expiry date refers to the last day of that month.

For HDPE containers, before first opening:

Do not store above 25°C.

For HDPE containers, after first opening:

Shelf life after first opening: 6 months

Do not store above 25 ºC.

Keep the container tightly closed, in order to protect from moisture.

For Aluminium/aluminium blister:

Do not store above 25 ºC.

For Aclar/aluminium blister:

Do not store above 25 ºC.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6 Contents of the pack and other information

What Mezzopram contains

The active substance is omeprazole (as omeprazole magnesium).

Each gastro-resistant tablet contains 10 mg omeprazole. Each gastro-resistant tablet contains 20 mg omeprazole. Each gastro-resistant tablet contains 40 mg omeprazole.

The other ingredients are:

Tablet core:

Sucrose, maize starch, liquid glucose, copovidone, povidone, talc, titanium dioxide (E171), methacrylic acid-ethyl acrylate copolymer (1:1), glycerol monostearate, propylene glycol, stearic acid, polysorbate 80, simeticone, cellulose, microcrystalline, macrogol 6000, crospovidone, silica colloidal anhydrous, magnesium stearate

Tablet coating:

Hypromellose, macrogol 6000, titanium dioxide (E171), talc, iron oxide, red (E172)

Only for Mezzopram 10 mg and Mezzopram 40 mg: Iron oxide, yellow (E172)

What Mezzopram look like and contents of the pack

Mezzopram 10 mg Dispersible Gastro-resistant Tablets: Light pink oval film-coated tablet (11.2 x 5.8 mm).

Mezzopram 20 mg Dispersible Gastro-resistant Tablets Pink, oval film-coated tablet with a breaking notch on both sides. The tablet can be divided into equal doses (14.2 x 7.2 mm).

Mezzopram 40 mg Dispersible Gastro-resistant Tablets Reddish oval film-coated tablet with a score line on both sides. The tablet can be divided into equal doses (18.2 x 9.0 mm).

Pack sizes:

Mezzopram is available in blister packs with 5, 7, 10, 14, 15, 20, 28, 30, 49, 50, 56, 60, 90, 98, 100 gastro-resistant tablets and in containers with 7, 14, 15, 28, 30, 56, 98, 100 gastro-resistant tablets

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Sandoz Limited

Park View, Riverside Way

Watchmoor Park

Camberley, Surrey

GU15 3YL

United Kingdom

Manufacturer

Salutas Pharma GmbH, Otto-von-Guericke-Allee 1, 39179 Barleben, Germany

Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia Lek Pharmaceuticals d.d.,Trimlini 2 D, 9220 Lendava, Slovenia LEK S.A., Ul. Podlipie 16 C, 95 010 Strykow, Poland LEK S.A., Ul. Domaniewska 50, 02-672 Warszawa, Poland

This leaflet was last revised in 04/2024.

The following information is intended for healthcare professionals only:

Stomach tube administration for doctors:

If the patient is unable to swallow, the tablets can be dissolved in still water and administered via a stomach tube. It is important to ensure that the suitability of the selected syringe and tube is carefully verified.

Administration via a stomach tube

  1. 1. Put the tablet into an appropriate syringe and fill the syringe with approximately 25 ml water and approximately 5 ml air. For some tubes, dispersion in 50 ml water is needed to prevent the pellets from clogging the tube.
  2. 2. Immediately shake the syringe for approximately 2 minutes to disperse the tablet.
  3. 3. Hold the syringe with the tip up and check that the tip has not clogged.
  4. 4. Attach the syringe to the tube whilst maintaining the above position.
  5. 5. Shake the syringe and position it with the tip pointing down. Immediately inject 5-10 ml into the tube. Invert the syringe after injection and shake it. Keep the syringe tip pointed upward as this will avoid clogging.
  6. 6. Turn the syringe with the tip down and immediately inject another 5-10 ml into the tube. Repeat this procedure until the syringe is empty.
  7. 7.

    Fill the syringe with 25 ml water and 5 ml air and repeat step 5 if necessary to wash down any sediment left in the syringe. Some tubes will require 50 ml water.

    SZ00000LT000 PIL.1077-1079.016.0D

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04416/1078

Last revision stated in the text: April 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Mezzopram 20 mg dispersible gastro-resistant tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Omeprazole
Strength 20 mg
Pharmaceutical form Gastro-resistant tablet
Reddish, oval film-coated tablet with a breaking notch on both sides. The tablet can be divided into equal doses (18.2 x 9.0 mm).
How is it taken Oral
Excipients Sucrose, Maize starch, Glucose, Copovidone, Povidone, Talc, Titanium dioxide (E 171), Methacrylic acid-ethyl acrylate copolymer (1:1), Glycerol monostearate, Propylene glycol, Stearic acid, Polysorbate 80, Simeticone, Cellulose, microcrystalline, Macrogol 6000, Crospovidone, Silica colloidal anhydrous, Magnesium stearate, Hypromellose, Iron oxide, red (E 172)
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life HDPE containers:
18 months
shelf life after first opening: 6 months
Do not store above 25 °C after first opening of the container. Keep the container tightly closed, in order to protect from moisture.
Aluminium/aluminium blister:
18 months
Aclar/aluminium blister:
1 year
Storage HDPE containers:
Do not store above 25°C.
For storage conditions of the medicinal product after first opening of the HDPE container, see section 6.3.
Aluminium/aluminium blister:
Do not store above 25 °C.
Aclar/aluminium blister:
Do not store above 25 °C.
Drug group (ATC) Drugs for acid related disorders, drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD), Proton pump inhibitors
  1. A Alimentary tract and metabolism drugs
    1. A02 Drugs for acid related disorders
      1. A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
        1. A02BC Proton pump inhibitors for peptic ulcer and GORD
          1. A02BC01 omeprazole
Marketing authorisation PL 04416/1078 (first authorised 5 July 2010)
Marketing authorisation holder Sandoz Limited
Codes GTIN 5015915907141 · BNF 01030500

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.